Potentiating cutaneous wound healing in young and aged skin with nutraceutical collagen peptides.


Journal

Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847

Informations de publication

Date de publication:
Jan 2021
Historique:
accepted: 15 07 2020
pubmed: 21 7 2020
medline: 22 9 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

Chronic wounds continue to be a burden to healthcare systems, with ageing linked to increased prevalence of chronic wound development. Nutraceutical collagen peptides have been shown to reduce signs of skin ageing, but their therapeutic potential for cutaneous wound healing remains undefined. To determine the potential for nutraceutical collagen peptides to promote cutaneous wound healing in vitro in the context of age. The potential for bovine- or porcine-derived nutraceutical collagen peptides to promote wound healing of primary cutaneous fibroblasts and keratinocytes derived from young and aged individuals in vitro was assessed by two-dimensional scratch and cell-viability assays and by immunofluorescence for the cell proliferation marker, Ki67. The achievement of peptide concentrations in vivo, equivalent to those exerting a beneficial effect on wound healing in vitro, was confirmed by pharmacokinetic studies of hydroxyproline, a biomarker for collagen peptide absorption, following peptide ingestion by healthy individuals over a wide age range. Results demonstrated significant nutraceutical collagen peptide-induced wound closure of both young and aged fibroblasts and keratinocytes, mediated by enhanced cellular proliferation and migration. Analysis of blood levels of hydroxyproline in young and aged individuals following porcine collagen peptide ingestion revealed peak serum/plasma levels after 2 h at similar concentrations to those exerting beneficial effects on wound healing in vitro. These data demonstrate the capacity for nutraceutical collagen peptides to promote cutaneous wound closure in vitro, at pharmacologically achievable concentrations in vivo, thereby offering a potential novel therapeutic strategy for the management of cutaneous wounds in young and aged individuals.

Sections du résumé

BACKGROUND BACKGROUND
Chronic wounds continue to be a burden to healthcare systems, with ageing linked to increased prevalence of chronic wound development. Nutraceutical collagen peptides have been shown to reduce signs of skin ageing, but their therapeutic potential for cutaneous wound healing remains undefined.
AIM OBJECTIVE
To determine the potential for nutraceutical collagen peptides to promote cutaneous wound healing in vitro in the context of age.
METHODS METHODS
The potential for bovine- or porcine-derived nutraceutical collagen peptides to promote wound healing of primary cutaneous fibroblasts and keratinocytes derived from young and aged individuals in vitro was assessed by two-dimensional scratch and cell-viability assays and by immunofluorescence for the cell proliferation marker, Ki67. The achievement of peptide concentrations in vivo, equivalent to those exerting a beneficial effect on wound healing in vitro, was confirmed by pharmacokinetic studies of hydroxyproline, a biomarker for collagen peptide absorption, following peptide ingestion by healthy individuals over a wide age range.
RESULTS RESULTS
Results demonstrated significant nutraceutical collagen peptide-induced wound closure of both young and aged fibroblasts and keratinocytes, mediated by enhanced cellular proliferation and migration. Analysis of blood levels of hydroxyproline in young and aged individuals following porcine collagen peptide ingestion revealed peak serum/plasma levels after 2 h at similar concentrations to those exerting beneficial effects on wound healing in vitro.
CONCLUSION CONCLUSIONS
These data demonstrate the capacity for nutraceutical collagen peptides to promote cutaneous wound closure in vitro, at pharmacologically achievable concentrations in vivo, thereby offering a potential novel therapeutic strategy for the management of cutaneous wounds in young and aged individuals.

Identifiants

pubmed: 32687652
doi: 10.1111/ced.14392
doi:

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-117

Subventions

Organisme : Rousselot

Informations de copyright

© 2020 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Références

Järbrink K, Ni G, Sönnergren H et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Syst Rev 2017; 6: 15.
Sen CK, Gordillo GM, Roy S et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009; 17: 763-71.
Gould L, Abadir P, Brem H et al. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen 2015; 23: 1-13.
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008; 453: 314-21.
Quirinia A, Viidik A. The influence of age on the healing of normal and ischemic incisional skin wounds. Mech Ageing Dev 1991; 58: 221-32.
Rittié L, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Resh Rev 2002; 1: 705-20.
Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93: 639-43.
Lambert CA, Colige AC, Lapière CM, Nusgens BV. Coordinated regulation of procollagens I and III and their post-translational enzymes by dissipation of mechanical tension in human dermal fibroblasts. Eur J Cell Biol 2001; 80: 479-85.
Asserin J, Lati E, Shioya T, Prawitt J. The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials. J Cosmet Dermatol 2015; 14: 291-301.
Iwai K, Hasegawa T, Taguchi Y et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem 2005; 53: 6531-6.
Ichikawa S, Morifuji M, Ohara H et al. Hydroxyproline-containing dipeptides and tripeptides quantified at high concentration in human blood after oral administration of gelatin hydrolysate. Int J Food Sci Nutr 2010; 61: 52-60.
Ohara H, Matsumoto H, Ito K et al. Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources. J Agric Food Chem 2007; 55: 1532-5.
Watanabe-Kamiyama M, Shimizu M, Kamiyama S et al. Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats. J Agric Food Chem 2010; 58: 835-41.
Shigemura Y, Iwai K, Morimatsu F et al. Effect of prolyl-hydroxyproline (pro-hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J Agric Food Chem 2009; 57: 444-9.
Ohara H, Ichikawa S, Matsumoto H et al. Collagen-derived dipeptide, proline-hydroxyproline, stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts. J Dermatol 2010; 37: 330-8.
Zhang Z, Wang J, Ding Y et al. Oral administration of marine collagen peptides from chum salmon skin enhances cutaneous wound healing and angiogenesis in rats. J Sci Food Agric 2011; 91: 2173-9.
Wang J, Xu M, Liang R et al. Oral administration of marine collagen peptides prepared from chum salmon (Oncorhynchus keta) improves wound healing following cesarean section in rats. Food Nutr Res 2015; 59: 26411. https://doi.org/10.3402/fnr.v59.26411
Hill DS, Robinson NDP, Caley MP et al. A novel fully-humanised 3D skin equivalent to model early melanoma invasion. Mol Cancer Ther 2015; 14: 2665-73.
Armstrong JL, Hill DS, McKee CS et al. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J Invest Dermatol 2015; 135: 1629-37.
Wright TJ, McKee C, Birch-Machin MA et al. Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. Clin Exp Dermatol 2013; 38: 421-3.
Kleinnijenhuis AJ, van Holthoon FL, Maathuis AJH et al. Non-targeted and targeted analysis of collagen hydrolysates during the course of digestion and absorption. Anal Bioanal Chem 2020; 412: 973-82.
Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999; 79: 1479-87.
Kudo M, Katayoshi T, Kobayashi-Nakamura K et al. H+/peptide transporter (PEPT2) is expressed in human epidermal keratinocytes and is involved in skin oligopeptide transport. Biochem Biophys Res Commun 2016; 475: 335-41.
Dawson RA, Goberdhan NJ, Freedlander E, MacNeil S. Influence of extracellular matrix proteins on human keratinocyte attachment, proliferation and transfer to a dermal wound model. Burns 1996; 22: 93-100.
Komine M, Rao LS, Kaneko T et al. Inflammatory versus proliferative processes in epidermis. Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NFkappa B and C/EBPbeta. J Biol Chem 2000; 275: 32077-88.

Auteurs

K Mistry (K)

Translation and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.

B van der Steen (B)

Rousselot BVBA, Meulestedekaai, Ghent, Belgium.

T Clifford (T)

Translation and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, Leicestershire, UK.

F van Holthoon (F)

Triskelion, Utrechtseweg, Zeist, The Netherlands.

A Kleinnijenhuis (A)

Triskelion, Utrechtseweg, Zeist, The Netherlands.

J Prawitt (J)

Rousselot BVBA, Meulestedekaai, Ghent, Belgium.

M Labus (M)

Translation and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.

B Vanhoecke (B)

Rousselot BVBA, Meulestedekaai, Ghent, Belgium.

P E Lovat (PE)

Translation and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.

A McConnell (A)

Translation and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, Tyne and Wear, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH